newsfilter
← Latest News
GlobeNewswire·

Small Pharma Announces TSXV Approval of Normal Course Issuer Bid

LONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announces that th